AI Terminal
Carl Zeiss Meditec AG
Earnings Release • Apr 12, 2019
74_rns_2019-04-12_a5b7d3c4-d5ea-4b9c-9494-3e5aa6ef4b1f.html
Earnings Release
Open in ViewerOpens in native device viewer
News Details
Ad-hoc | 12 April 2019 10:03
Carl Zeiss Meditec AG reports further growth and defines expectations for fiscal year 2018/19
Carl Zeiss Meditec AG / Key word(s): Half Year Results
Carl Zeiss Meditec AG reports further growth and defines expectations for fiscal year 2018/19
12-Apr-2019 / 10:03 CET/CEST
Disclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014, transmitted by DGAP – a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.
| Carl Zeiss Meditec AG reports further growth and defines expectations for fiscal year 2018/19 |
| Jena, April 12, 2019 Carl Zeiss Meditec (ISIN: DE0005313704) has grown revenues to around EUR 667 million in the first six months of fiscal year 2018/19, based on preliminary data. This corresponds to a growth rate of approx. 9% against the previous year’s value of EUR 613.7 million. Adjusted for currency effects, the growth rate was around 7%. Carl Zeiss Meditec now further defines its expectations for the full year 2018/19: Revenue is expected to reach between EUR 1,350 million and EUR 1,420 million (previous year: EUR 1,280.9 million). Earnings before interest and taxes (EBIT) are expected to rise significantly in the first half of 2018/19 to a level of around EUR 110 million (previous year: EUR 88.2 million). EBIT margin (EBIT as a % of revenue) will amount to around 16.5% in the first half of 2018/19 (previous year: 14.4%). The increase was supported by a positive trend in product mix with a high share of recurring revenue, in particular. In light of these developments, Carl Zeiss Meditec raises the expectation for full year EBIT margin. EBIT margin is now expected to reach a corridor of 15.0% – 17.5% (previously: 14.0% – 16.0%). EBIT margin had amounted to 15.4% in the previous year 2017/18. The six months 2018/19 financial report will be published on May 6, 2019. |
Contact for investors and press
Sebastian Frericks
Director Investor Relations
Carl Zeiss Meditec AG
Tel.: +49 3641 220-116
E-Mail: [email protected]
12-Apr-2019 CET/CEST The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.dgap.de
| Language: | English |
| Company: | Carl Zeiss Meditec AG |
| Göschwitzer Str. 51-52 | |
| 07745 Jena | |
| Germany | |
| Phone: | +49 (0)3641 220-0 |
| Fax: | +49 (0)3641 220-112 |
| E-mail: | [email protected] |
| Internet: | www.zeiss.de/meditec-ag/ir |
| ISIN: | DE0005313704 |
| WKN: | 531370 |
| Indices: | MDAX, TecDAX |
| Listed: | Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Berlin, Dusseldorf, Hamburg, Hanover, Munich, Stuttgart, Tradegate Exchange |
| EQS News ID: | 799331 |
| End of Announcement | DGAP News Service |